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Antibody responses to the synthetic terpolymer L-glutamic acid~°-L-alanine  3°- 
L-tyrosine  ~° (GAT)  1 in mice are controlled by H-2-1inked-immune response (Ir) 
genes (1). Injection of nonresponder mice, H-2  p,q,8, with GAT fails to stimulate 
GAT-specific plaque-forming cell (PFC) responses but does activate suppressor 
T cells (Ts cells) specific for GAT (GAT-Ts cells) (1, 2). GAT-Ts cells inhibit the 
development of GAT-specific IgG PFC responses by syngeneic mice immunized 
with GAT complexed to the carrier methylated bovine serum albumin (GAT- 
MBSA) in vivo and in vitro. 
Extracts prepared from lymphoid cells of GAT-primed nonresponder, but not 
responder,  mice specifically inhibit the development of antibody responses to 
GAT-MBSA by normal syngeneic nonresponder mice in vivo and in vitro (3). 
The suppressive factor in these extracts is a protein of approximately 45,000 mol 
wt  (4)  which can  be  extracted from purified T  cells  but  not  B  cells,  and  is 
therefore referred to as GAT-TsF (5). GAT-TsF specifically binds to insolubilized 
GAT and can be eluted with 3.0 M KC1. Despite this affinity GAT-TsF does not 
bear ~, ~1, ~2a, ~/2b, or a-heavy chain or K-light chain constant region determi- 
nants (4). However, GAT-TsF is absorbed by insolubilized antisera specific for 
determinants encoded by the I region of the H-2 gene complex (4), and therefore 
belongs to the same class of immunosuppressive molecules described by Tada et 
al.  (6). In  the crude  lymphoid cell  extracts,  GAT-TsF is  associated with an 
immunologically  detectable fragment of GAT (4). However, the amount of GAT 
associated with  GAT-TsF  is,  by  itself,  insufficient to  cause  suppression  (4). 
Furthermore, GAT-TsF purified by absorption to and elution from insolubilized 
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GAT  no  longer  contains  detectable GAT;  presumably,  the  fragment  of GAT 
complexed to GAT-TsF is displaced by insolubilized GAT. Nevertheless, purified 
GAT-TsF bears Ia antigen and is suppressive, suggesting that the original GAT 
fragment associated with GAT-TsF is not essential for suppression.  However, 
this  observation  does  not  establish  that  antigen  is  unnecessary  for  specific 
suppressive activity since the assay for activity requires the presence of GAT- 
MBSA. 
GAT-TsF has been detected in extracts from two nonresponder strains of mice 
(DBA/1 and A.SW) (3). In addition,  an extract from GAT-primed DBA/1 mice 
inhibits  the response to GAT-MBSA by spleen cells from a  histoincompatible 
nonresponder  strain  of mice  (A.SW)  but  not  a  histoincompatible  responder 
strain  (C57BL/6) (5). 
The  observations  that  GAT-TsF  is  associated  with  a  fragment  of GAT  in 
crude extracts and that  GAT-TsF from one strain  of nonresponder  mice could 
suppress  another  histoincompatible  nonresponder  strain  of mice  distinguish 
this  molecule  from  the  carrier-specific  TsF  described  by Tada  et  al.  (6,  7). 
Carrier-specific  TsF  is  not  associated  with  antigen  and  suppresses  immune 
responses only when donors and recipients are syngeneic at I-J. 
To determine whether the suppression by GAT-TsF across histocompatibility 
barriers  was  peculiar  to  the  two  strains  of  mice  tested  or  was  a  general 
characteristic  of the GAT system, the following experiments were performed. 
GAT-TsF from  mice bearing  the  three  nonresponder  H-2 ~.q,"  haplotypes on a 
variety of non-H-2 backgrounds was prepared and analyzed for specific suppres- 
sor activity on in vitro PFC responses to GAT-MBSA by spleen cells from mice 
that were syngeneic or allogeneic with the GAT-TsF donor. 
Materials  and Methods 
Mice.  C57BL/10  (H-2h),  P/J  (H-2"),  DBA/1  (H-2q),  SWR  (H-2q),  and  SJL  (H-2  s)  mice were 
purchased from The Jackson Laboratory, Bar Harbor, Maine. A.SW (H-2  s) and B10.S (H-2  s) mice 
were bred in the animal facilities at The Jewish Hospital by brother-sister mating of the offspring 
of breeder pairs obtained from The Jackson Laboratory.  B10.P (H-2") mice were kindly provided 
by Dr. Donald Shreffler, Washington University School of Medicine. Mice used were 2- to 8-too-old 
and were maintained on laboratory chow and water ad lib. 
Antigens.  GAT, mol wt 45,000,  was purchased from Miles Laboratories, Inc., Miles Research 
Products, Elkhart, Ind. MBSA (Worthington Biochemical Corp., Freehold, N. J.), sheep erythro- 
cytes (SRBC), GAT and GAT-MBSA were prepared as described previously (1). 
Preparation of Cell-Free Extracts.  Cell-free extracts of lymphoid cells from GAT-primed mice 
were prepared  as previously described  (3).  Briefly, mice were injected i.p.  with 10  ~g GAT in 
Maalox (Wm.  H. Roher, Inc., Fort Washington,  Pa.).  These mice were sacrificed 3-7 days later, 
and  single cell suspensions  of spleens  and  thymuses  were  prepared,  pooled,  washed  twice in 
Hanks' balanced salt solution, and resuspended to 6 ×  l0  s cells/ml in Eagle's minimum essential 
medium  supplemented  with  4  mM  Hepes,  2  mM  L-glutamine  and  50  U  each  penicillin  and 
streptomycin  (Microbiological Associates, Walkersville, Md.). The cells were senicated at 7°C in 
a  Soncifier Cell Disruptor  model W-140-E  (Heat Systems-Ultrasonics,  Inc.,  Plainview, N.  Y.). 
The lysate was centrifuged at 40,000 g for 30 min and the supernate collected and stored at -80°C. 
Antisera.  Alloantisera specific for the (I-B, -J, -E, -C; S; G)  b (anti-I  b) and (I, S, G)  ~ (anti-I  ~) 
regions of the H-2 complex were donated by Dr. Shreffier. Anti-I  b was prepared by immunizing 
[B10.A (2R)  ×  C3H.Q]F1  with B10.A (4R)  lymphoid cells. Anti-I  ~ was prepared by immunizing 
(A.TL × A.TFR3)F1 with A.TH lymphoid cells. Anti-GAT sera was obtained from rabbits 7 days 
after the second subcutaneous immunization with 1 mg GAT in complete Freund's adjuvant. 
Preparation  of Immunoadsorbents.  GAT-Sepharose  4B:  GAT was  coupled to  amino hexyl- 
Sepharose 4B (Pharmacia Fine Chemicals, Piscataway, N. J. ) as previously described (4). Briefly, JUDITH  A.  KAPP  999 
GAT was dissolved in water and coupled to the beads with 1-ethyl-3-(3-dimethyl-aminopropyl)- 
carbodiimide (Story Chemical Corp., Muskegon, Mich.). The coupling conditions were empirically 
adjusted such that 1-2 mg GAT was coupled to 1 ml of packed Sepharose. 
Anti-GAT, anti-I b, and anti-Is: all sera were heat inactivated at 56°C for 30 rain and the globulin 
fractions were  prepared  by  precipitation  with  50%  ammonium  sulfate.  The precipitates  were 
dissolved in and extensively dialyzed against 0.5 M NaC1 containing 0.1 M NaHCOa. The globulin 
fractions of these sera were coupled to CNBr-activated Sepharose 4B (Pharmacia Fine Chemicals) 
according to the manufacturers directions. Coupling conditions were adjusted to obtain 2 mg of 
protein per ml packed Sepharose. 
Use of  Immunoadsorbents.  Extracts were diluted 1:10, applied to immunoadsorbent columns, 
and reacted at 4°C for 1-2 h. The unbound material was collected, the columns extensively washed 
with Hanks' balanced salt solution, and bound material was eluted with 3.0 M  KCI.  KC]  was 
removed from the eluates by filtration through Sephadex G-25 (Pharmacia Fine Chemicals) (4). 
Cell Cultures, Assay of GAT-TsF and PFC Assay.  Replicate 1-ml cultures containing 8-10  × 
10  e spleen cells were established according to the modifications of the Mishell-Dutton system used 
in our laboratory (8) and dilutions of GAT-TsF and 5/~g GAT as GAT-MBSA or SRBC was added 
at culture initiation. PFC responses were assayed 5 days later using SRBC or GAT coupled to 
SRBC (GAT-SRBC) as indicator cells. The activity of GAT-TsF is expressed at Ss0 U/ml which is 
defined as the inverse of the final dilution of extracts that causes 50% suppression of the PFC 
response. If no suppressive activity is observed at the lowest dilution tested, the titer is expressed 
as less than the inverse of the dilution. Conversely, if the 50% end point is not obtained at the 
highest dilution tested, the titer is recorded as greater than that dilution. 
Results 
GAT Stimulates Production  of GAT-TsF in Nonresponder  Strains of Mice 
Bearing H-2  ~,q,s Haplotypes.  Extracts prepared from lymphoid cells of GAT- 
primed B10.P  (H-2p), DBA/1  (H-2  ~)  and A.SW  (H-2  s)  mice were diluted and 
added to cultures containing spleen cells syngeneic with the GAT-TsF donors 
stimulated with  SRBC  or GAT-MBSA  (Fig.  1).  Control  cultures containing 
B10.P, DBA/1, or A.SW spleen cells stimulated with GAT-MBSA in the absence 
of any extracts developed 340, 1,375, and 800  GAT-specific  IgG PFC/culture, 
respectively. Although not shown, none of these extracts suppressed the IgM or 
IgG PFC responses to SRBC at dilutions of 1/400 or greater. Clearly, GAT-TsF 
can be produced by GAT-primed mice bearing any one of the three nonrespender 
haplotypes.  Repeated  titrations  of a  given  extract  have  been  remarkably 
consistent although some variation in suppressive activity from one batch to 
another has been observed (3). 
Suppression  of  Immune Responses of  Nonresponder  Mice by Allogeneic GA T- 
TsF.  Suppression of GAT-MBSA  responses by spleen cells from five nonre- 
spender strains of mice by an H-2  q GAT-TsF is shown in Table I. PFC responses 
to  GAT-MBSA  by  nonresponder  mice  bearing  H-2"  (P/J)  and  H-2  ~ (SJL) 
haplotypes but  not responder mice bearing H-2  b (C57BL/10) haplotype were 
specifically  suppressed  by  H-2  q  (DBA/1  or  SWR)  GAT-TsF.  Furthermore, 
responses  by  spleen  cells  from  congenic strains  (A.SW,  B10.S  and  B10.P) 
bearing nonresponder H-2 haplotypes were also suppressed by DBA/1 GAT-TsF 
regardless of the origin of non-H-2 genes. 
Extracts  from  GAT-primed B10.P  and  A.SW  mice specifically suppressed 
PFC responses by B10.P,  DBA/1, and A.SW spleen cells (Table II). The data in 
Tables I and II demonstrate that GAT-TsF from donors bearing any one of the 
three nonresponder haplotypes reciprocally suppressed recipients bearing any 
one of the three nonresponder haplotypes. In this experiment the activity of 1000  IMMUNOSUPPRESSIVE  FACTOR(S)  FROM  NONRESPONDER  MICE 
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FIG.  1.  In vitro analysis of lymphoid cell extracts from GAT-primed DBA/1, A.SW,  and 
B10.P mice. All extracts were prepared from pooled thymus and spleen cells (6  x  l0  s cells/ 
ml) from mice primed i.p. 3 days earlier with 10/~g GAT in Maalox. Extracts were diluted 
and  added  to  spleen  cells  from  normal  syngeneic mice  at  culture  initiation.  IgG  PFC 
responses stimulated by GAT-MBSA and SRBC  (not shown) were assayed after 5 days. 
Suppression is expressed as Sso U/ml which is the inverse of the dilution of extract that 
causes 50% inhibition of the PFC response by control cultures. 
GAT-TsF from A.SW mice was somewhat lower than that from B10.P or DBA/1 
mice  (Table  I).  Multiple  extracts  prepared  from  A.SW  mice  demonstrate 
fluctuations in levels of activity and frequently contain less activity than H-2  p 
or H-2  q extracts (data not shown). 
The data in Table I demonstrated that non-H-2 genes did not detectably alter 
the susceptibility of recipient nonresponder spleen cells to a  given GAT-TsF. 
Furthermore, nonresponder mice bearing the H-2  p or H-2 s haplotypes on  a 
background of responder (C57BL/10 or A) genes were capable of producing GAT- 
TsF  (Fig.  1  and  Table  II),  suggesting that  non-H-2  genes  did  not  control 
production  of  GAT-TsF.  The  possibility  that  non-H-2  genes  might  subtly 
regulate production of GAT-TsF was examined in a greater detail by comparing 
suppressive  activities  of extracts  from  GAT-primed mice  bearing  the H-2 s 
haplotype and various non-H-2 genes on the immune response by DBA/1 spleen 
cells. In the experiment shown in Table III, no detectable differences  were found 
in the level or specificity of suppression mediated by extracts of lymphocytes 
prepared simultaneously from age matched SJL, A.SW, or B10.S mice 3 days 
after priming  with  GAT,  suggesting that  responder  non-H-2  genes  do  not 
regulate production of GAT-TsF. 
Is  Suppression  of Responses  by  Syngeneic  and  Allogeneic  Spleen  Cells 
Mediated  by  the  Same  Molecule?  Although GAT-TsF mediated suppression 
of PFC responses by syngeneic and allogeneic recipient spleen cells which was 
antigen-specific, it is still possible that suppression of responses by allogeneic 
spleen cells is  mediated by a  moiety distinct from that  active in  syngeneic 
recipient spleen cells.  We have previously demonstrated that suppression of JUDITH  A.  KAPP 
TABLE  I 
Suppression of Responses by Nonresponder 
H-2  q Mice 
Mice by GAT-TsF from 
1001 
Spleen cells*  H-2  SRBC  GAT-MBSA 
$5o U/rnl$ 
DBA/1  q  <400  1,600§ 
P/JH  p  <400  1,600 
SJL  s  <400  1,200 
C57BL/10¶  b  <400  400 
A.SW  s  <400  1,500 
B10.S  s  <400  1,500 
B10.P  p  <400  1,500 
*  Spleen  cells  cultured  at  8-10  x 106  cells/ml. 
Inverse  of  the  final  dilution  GAT-TsF causing  50% suppression  of  the PFC 
response. 
§  Data in  this  Table  are  compiled  from several  experiments  in  which an H-2" 
GAT-TsF was titrated  on the  immune response  by  spleen  cells  from DBA/1 
and other nonresponder strains.  The activity  of GAT-TsF in individual 
experiments  was normalized  to  the average  activity  on DBA/1 responses  of 
1,600  S~o  U/ml. 
II  Spleen cells  from P/J mice were treated  with  GAT-TsF from SWR (H-2") 
mice. 
¶ C57BL/10 mice  are  responders  to  GAT. 
TABLE  II 
Suppression of Responses by Nonresponder Mice of Different 
Haplotypes  by GAT-TsF from H-2  p or H-2' Mice in Vitro 
Spleen  cells$  H-2  ~  GAT-TsF  H-T GAT-TsF 
Strain  H-2  SRBC  GAT-MBSA  SRBC  GAT-MBSA 
sso U/ml* 
B10.P  p  <400  1,000  <400  1,000 
DBA/1  q  <400  2,100  <200  930 
A.SW  s  <400  1,600  <400  850 
* Inverse final dilution of extracts from  B10.P  (H-2P)  or A.SW  (H-2  s)  mice 
causing 50% suppression of the immune response. 
$ Spleen cells cultured a~ 8-10 x  106 cells/ml, 
responses in DBA/I spleen cells  by DBA/1 GAT-TsF  is  mediated by a factor that 
bears determinants encoded by the  I region of  the H-2  q complex (4).  Therefore, 
a crude extract from GAT-primed  A.SW  mice and the extract after absorption 
with insolubilized anti-I  b or anti-I  s alloantisera  were tested for suppression of 
responses by spleen cells  from DBA/1  and A.SW  mice (Table IV). Titration of 
these materials on syngeneic spleen cell  responses indicated that H-2  s  GAT-TsF 
was absorbed by an alloantisera reactive against I  s  but not I  b. Similarly, GAT- 
specific suppression of  the PFC  response by DBA/1  spleen cells  occurred when 
these cells were incubated with the untreated H-T  GAT-TsF  and the extract 
which was passed over an anti-I  b  immunoadsorbent.  Unbound  material from an 
anti-I  s  immunoadsorbent  failed to suppress the DBA/1  PFC  response. 
Suppression of PFC Responses in Syngeneic and Allogeneic Recipient Spleen 
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TABLE III 
Immune Responses  by DBA/1 Spleen Cells are Suppressed by 
Extracts from Mice Bearing the H-2" Haplotype and Various 
Non-H-2 Genes 
Source  H-2 Haplotype  SRBC  GAT-MBSA 
GAT-TsF  of donor 
$5. U/ml* 
DBA/1  q  <400  1,450 
SJL  s  <400  1,150 
A.SW  s  <400  1,350 
B10.S  s  <400  1,500 
* See Table I. 
TABLE IV 
Suppressive Moiety in GA T-TsF from A .SW Mice Bears Antigens Encoded 
by the H-2 Complex 
A.SW GAT-TsF 
Treatment 
A.SW  DBA/1 
SRBC  GAT-MBSA  SRBC  GAT-MBSA 
$5o U/ml* 
None  <400  1,150  <200  930 
Absorption with anti-I  b  480  2,100  <200  1,600 
Absorption with anti-I  s  410  <400  <200  <200 
* See Table I. 
TABLE  V 
Suppression of Responses  by Syngeneic and Allogeneic Spleen Cells with 
Crude and Purified GA T- TsF 
Treatment of 
Group  DBA/1 GAT-TsF  DBA/1  B10.S 
A 
B 
C 
D 
E 
$5o U/ml* 
None  3,500  3,800 
Absorbed by Anti-GAT-Sepharose  500  NT* 
Absorbed by GAT-Sepharose  <400  NT 
Eluted from GAT-Sepharose (GAT-TsFP)  5,600  5,800 
GAT-TsFP Absorbed by Anti-GAT-Sepharose  5,800  NT 
* Suppressive activity  was titrated  on PFC responses to GAT-MBSA.  Although not 
shown the immune responses to SRBC by DBA/1 or B10.S spleen cells  were not 
suppressed by any of  the GAT-TsF fractions  tested  at  dilutions  of->  1/400. 
* Not tested. 
to  GAT-MBSA  by  allogeneic  nonresponder  mice,  GAT-TsF  differs  from  the 
carrier specific TsF described by Tada et al.  (7) in that GAT-TsF is associated 
with a  fragment of immunologically recognizable antigen.  An experiment was 
designed to determine whether association with a  GAT fragment accounted for 
suppression of allogeneic recipient mice by GAT-TsF (Table V). GAT-TsF from 
DBA/1 mice was specifically suppressive for both DBA/1 and B10.S GAT-MBSA 
responses  (group  A).  Association  of immunoreactive  GAT  with  GAT-TsF  in 
crude  extracts  was verified by absorbing the  crude  extract  with  insolubilized JUDITH  A.  KAPP  1003 
rabbit anti-GAT globulin (group B) which reduced the $50 titer by 85%. GAT- 
TsF was also bound by GAT-Sepharose (group C) and was eluted from GAT- 
Sepharose with 3.0 M KC1 (group D). The apparent increase in activity ofeluted 
GAT-TsF is frequently observed and is most likely due to removal of nonspecific 
enhancing material  present in  crude extracts  (3). Purified GAT-TsF,  eluted 
from  GAT-Sepharose,  is  no  longer  absorbed  by  rabbit  anti-GAT-Sepharose 
(group E). Nevertheless, the PFC response by B10.S spleen cells to GAT-MBSA 
was suppressed by crude as well as purified DBA/1 GAT-TsF (group D). This 
observation suggests that the fragment of GAT associated with GAT-TsF in 
crude extracts is not responsible for the ability of GAT-TsF to suppress anti- 
GAT-MBSA PFC responses across histocompatibility barriers. 
Discussion 
These experiments demonstrate that lymphoid cell extracts from GAT-primed 
H-2  p mice, like extracts from mice bearing the other nonresponder haplotypes, 
H-2 q and H-2 s (3), contain GAT-specific immunosuppressive factors (Fig. 1). In 
addition, GAT-spocific suppression of responses by allogeneic (H-2  s) nonresponder 
spleen cells by DBA/1 (H-2  q) GAT-TsF has been confirmed (5) and extended to 
other allogeneic nonresponder recipient spleen cells (Table I).  Suppression by 
allogeneic  GAT-TsF is  not restricted  by the  presence of responder non-H-2 
genes in recipients, since DBA/1 GAT-TsF suppressed responses by spleen cells 
from SJL  (H-2  s)  and the congeneic strains  of A.SW  (H-2 s)  and B10.S  (H-2 s) 
equally (Table I).  More importantly, all nonresponder strains of mice, regard- 
less of the source of non-H-2 genes are suppressed by GAT-TsF from all other 
strains of mice bearing the nonresponder H-2 p,q's haplotypos (Tables I and II). 
Extracts  prepared  from mice bearing the H-2 ~ haplotypes on non-H-2  gene 
backgrounds of SJL,  A, or C57BL/10 suppressed the GAT-MBSA response of 
DBA/1 spleen cells with no detectable differences in antigen specificity or level 
of activity  (Table  III)  suggesting that  non-H-2  genes  do  not  modulate the 
production of GAT-TsF. 
Previously published data, demonstrated that DBA/1 GAT-TsF bears deter- 
minants encoded by the I  region of the H-2  gene complex (7). Absorption of 
A.SW GAT-TsF by insolubilized alloantisera specific for I subregion of the H-T, 
but not H-2  b, gene complex demonstrates that GAT-TsF from a second nonre- 
sponder strain of mice bears determinants that map between the H-2K  and H- 
2D  regions  (Table  IV).  Furthermore, the substance in A.SW GAT-TsF that 
suppressed responses by allogeneic recipient spleen cells also contains determi- 
nants encoded by the H-2 ~ gene complex (Table V). This observation suggests, 
but does not prove, that suppression of responses by syngeneic and allogeneic 
spleen cells is mediated by the same molecules. The conclusion that suppression 
by GAT-TsF does not require that donors and recipients are identical at the I-J 
subregion is tenuous since the/-J subregions of H-2" and H-2q have not yet been 
identified by recombination. Thus, the argument could be made that I-J p, I-J q, 
and I-J ~ genes encode molecules that contained shared specificities and that 
suppression by GAT-TsF across histocompatibility barriers actually represents 
cross-reactivity. Indirect evidence against this possibility has been obtained by 
Th~ze et al.  who have shown that suppressive factors obtained from BALB/c 1004  IMMUNOSUPPRESSIVE  FACTOR(S)  FROM  NONRESPONDER  MICE 
and B10.BR mice primed with the copolymer L-glutamic-acid~°-L-tyrosine  5° (GT) 
bear distinct alloantigens encoded by the [-J  subregion  and nevertheless 
reciprocally  suppress GT-MBSA  responses (9). 
One mechanism by which GAT-TsF suppresses GAT-MBSA  PFC responses is 
by stimulation of  GAT-Ts cells  in the recipient  (10).  In addition,  crude extracts 
containing GAT  complexed to GAT-TsF stimulates GAT-Ts cells  in recipient 
mice whereas purified  GAT-TsF containing no detectable  GAT  does not (11). 
Furthermore, the addition of small amounts of GAT, in concentrations too low to 
stimulate Ts cells independently, to purified GAT-TsF restores the capacity to 
stimulate GAT-Ts cells (11). This observation raised the possibility that GAT- 
TsF complexed to a fragment of GAT (as it is found in crude extracts) might 
suppress across histocompatibility barriers by virtue of stimulating autologous 
GAT-Ts  cells  in  the  recipient  and  thereby  masking  potential  restrictions 
between donors and recipients. To test this possibility, crude DBA/1 GAT-TsF 
was analyzed for the presence of immunoreactive GAT, and another portion of 
this extract was absorbed to GAT-Sepharose and purified GAT-TsF that was 
subsequently eluted from GAT-Sepharose was re-examined for the presence of a 
fragment of GAT. Each of these fractions were assayed for functional activity 
(Table V). Crude GAT-TsF containing GAT and purified GAT-TsF containing 
no detectable GAT determinants suppressed allogeneic as well as syngeneic 
responses (Table V). Thus, the ability of GAT-TsF to suppress across histocom- 
patibility barriers cannot be attributed to the residual GAT complexed to GAT- 
TsF. 
To  date  all  antigen-specific  suppressor  T-cell  factors  bear  determinants 
encoded by the H-2  gene complex (reviewed in 12). Comparison of those TsF 
that bear alloantigens encoded by the I-J region indicates variability in strain 
restrictions between donors and recipients. The discrepancy between require- 
ments for syngenicity at I-J between GAT-TsF and carrier-specific TsF remains 
unresolved. Data presented here demonstrate that suppression of syngeneic and 
allogeneic PFC  responses are mediated by the same molecules and that the 
association of GAT-TsF with a fragment of GAT does not mask inherent strain 
restrictions between donors and recipients of GAT-TsF.  At least two significant 
differences remain between the  GAT-TsF  and  carrier-specific TsF  systems. 
First,  carrier-specific TsF  is  analyzed by  measuring suppression  of hapten- 
specific responses stimulated by complexes of hapten and homologous carriers, 
whereas suppression by GAT-TsF is measured on PFC response to GAT itself. 
Second, the activity of GAT-TsF is  analyzed on primary-immune responses 
whereas the activity of carrier-specific TsF is routinely analyzed on secondary 
PFC  responses.  Data  from several other systems demonstrate that  efficient 
collaboration between antigen-primed T cells and macrophages (Mob) or B cells 
requires that these cells are syngeneic at the I region of the major histocompat- 
ibility complex; whereas these restrictions do not appear to govern interactions 
between M~b and virgin T cells or B cells, (Reviewed in 13-16). By analogy, the 
discrepancy between requirements for syngenicity between donors and recipi- 
ents of GAT-TsF and carrier-specific TsF may be a function of the immunologi- 
cal status of the recipient rather than a  fundamental difference between the 
mediators. Experiments to resolve this issue are currently in progress. JUDITH  A.  KAPP  1005 
Summary 
The synthetic terpolymer of L-glutamic acid6°-L-alanine3°-L-tyrosine  1°  (GAT) 
fails to  stimulate development of GAT-specific antibody responses  in  nonre- 
sponder mice but  stimulates development of GAT-specific suppressor  T  cells 
that inhibit the development of normal anti-GAT plaque-forming cell responses 
to GAT complexed to methylated bovine serum albumin (MBSA). Extracts from 
lymphoid cells  of GAT-primed  but  not  control,  nonresponder  (DBA/1)  mice 
contain a  T-cell factor (GAT-TsF) that also specifically suppresses responses to 
GAT-MBSA by normal syngeneic spleen cells. The experiments reported in this 
communication demonstrate  that:  (a)  extracts  from  all  GAT-primed  nonre- 
sponder mice tested contain GAT-TsF;  (b)  non-H-2  genes do not restrict the 
production of GAT-TsF; (c) all nonresponder strains of mice regardless of their 
non-H-2 genes are suppressed by GAT-TsF from all other strains bearing the 
nonresponder H-2 p,q," haplotypes; (d) suppression of GAT-MBSA responses by 
both  syngeneic and  allogeneic  nonresponder  spleen  cells  is  mediated  by  a 
molecule  encoded  by  the  H-2  gene  complex;  and  (e)  both  syngeneic  and 
allogeneic nonresponder mice are suppressed by purified GAT-TsF that lacks 
immunoreactive GAT. 
It is a pleasure to thank Rita Allen and Isabel Diego, whose technical  expertise contributed  to the 
success of these experiments, and Sally Menkhus  who skillfully  typed this manuscript. 
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